563 related articles for article (PubMed ID: 16808333)
1. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
[TBL] [Abstract][Full Text] [Related]
3. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
[TBL] [Abstract][Full Text] [Related]
6. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
8. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
10. A seroprevalence study of poliovirus antibody in the population of northern Greece.
Frantzidou F; Diza E; Halkia D; Antoniadis A
Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
[TBL] [Abstract][Full Text] [Related]
11. Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece.
Pliaka V; Filliponi ME; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2011 Oct; 17(10):1554-62. PubMed ID: 21375661
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
Böthig B; Danes L; Dittmann S
Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
[TBL] [Abstract][Full Text] [Related]
13. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
14. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province].
Shen Y; Zhao Y; Liu D
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):335-8. PubMed ID: 8697935
[TBL] [Abstract][Full Text] [Related]
16. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
17. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus neutralizing antibody persistence after vaccination with the Sabin vaccine: a follow-up study.
Farisano G; Trivello R; Moschen ME; Bonello C; Baldo V; Moretti G; Majori S; Marin F; Piron L; Renzulli G
Ann Clin Lab Sci; 1995; 25(2):200-6. PubMed ID: 7785968
[TBL] [Abstract][Full Text] [Related]
19. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
Deshpande JM; Dave KH
Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus vaccine strains in sewage and river water in South Africa.
Pavlov DN
Can J Microbiol; 2006 Aug; 52(8):717-23. PubMed ID: 16917529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
